Alembic Pharmaceuticals has designated Mr. Ramesh Juneja as Senior Management Personnel, effective June 1, 2026. Mr. Juneja brings extensive experience in pharmaceutical sales and marketing, having held leadership roles at major companies like Sun Pharmaceutical Industries and Cipla. His prior experience includes founding a business advisory and co-founding a health tech venture, along with leading the pan-India launch of Netmeds’ B2B and express store businesses. This appointment is in line with regulatory requirements.
Key Appointment in Senior Management
Alembic Pharmaceuticals Limited has announced the designation of Mr. Ramesh Juneja as Senior Management Personnel. This appointment is effective from June 1, 2026, and has been formally communicated to the stock exchanges. This move is in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Mr. Ramesh Juneja’s Profile
Mr. Juneja possesses a strong background in the pharmaceutical sector, with over three decades of experience in sales and marketing. He holds a pharmacy degree and an MBA, complemented by executive development programs from prestigious institutions. His career highlights include leading significant business growth and market expansion initiatives at organizations such as Sun Pharmaceutical Industries and Cipla. He has also been instrumental in developing high-performing teams across various therapeutic areas.
Before joining Alembic Pharmaceuticals, Mr. Juneja founded Ramesh Juneja Business Advisory and co-founded BJW Health Pvt. Ltd. He also served as Senior Vice President at Reliance Retail, where he played a key role in the pan-India launch of Netmeds’ B2B operations and its express store formats. His expertise is expected to contribute significantly to Alembic Pharmaceuticals’ strategic objectives.
Disclosure Details
The company has provided detailed information as required under the relevant SEBI regulations. This includes the reason for the change, which is the designation as Senior Management Personnel, and the effective date. A comprehensive brief profile of Mr. Juneja, highlighting his educational qualifications and extensive professional experience, has also been shared. Any disclosure of relationships between directors is noted as ‘Not Applicable’.
Source: BSE
